nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallium nitrate—BGLAP—forelimb zeugopod—peripheral nervous system neoplasm	0.0567	0.209	CbGeAlD
Gallium nitrate—BGLAP—skull—peripheral nervous system neoplasm	0.0296	0.109	CbGeAlD
Gallium nitrate—BGLAP—forelimb—peripheral nervous system neoplasm	0.0285	0.105	CbGeAlD
Gallium nitrate—BGLAP—arm—peripheral nervous system neoplasm	0.0245	0.0904	CbGeAlD
Gallium nitrate—IL1B—forelimb—peripheral nervous system neoplasm	0.0244	0.09	CbGeAlD
Gallium nitrate—TF—pons—peripheral nervous system neoplasm	0.0229	0.0847	CbGeAlD
Gallium nitrate—ATP6V1B2—ganglion—peripheral nervous system neoplasm	0.018	0.0665	CbGeAlD
Gallium nitrate—RRM2—Synthesis and interconversion of nucleotide di- and triphosphates—NME1—peripheral nervous system neoplasm	0.0162	0.0604	CbGpPWpGaD
Gallium nitrate—IL1B—Hematopoietic Stem Cell Differentiation—MXI1—peripheral nervous system neoplasm	0.016	0.0597	CbGpPWpGaD
Gallium nitrate—TF—Differentiation Pathway—ALK—peripheral nervous system neoplasm	0.0142	0.0532	CbGpPWpGaD
Gallium nitrate—TF—ganglion—peripheral nervous system neoplasm	0.0117	0.0434	CbGeAlD
Gallium nitrate—BGLAP—Regulation of retinoblastoma protein—SMARCB1—peripheral nervous system neoplasm	0.009	0.0336	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—trigeminal ganglion—peripheral nervous system neoplasm	0.00884	0.0327	CbGeAlD
Gallium nitrate—ATP6V1B2—parotid gland—peripheral nervous system neoplasm	0.00834	0.0308	CbGeAlD
Gallium nitrate—RRM2—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.00817	1	CbGdCrCtD
Gallium nitrate—Rales—Isotretinoin—peripheral nervous system neoplasm	0.00792	0.0175	CcSEcCtD
Gallium nitrate—Rales—Tretinoin—peripheral nervous system neoplasm	0.00792	0.0175	CcSEcCtD
Gallium nitrate—ATP6V1B2—brainstem—peripheral nervous system neoplasm	0.00782	0.0289	CbGeAlD
Gallium nitrate—Rales—Melphalan—peripheral nervous system neoplasm	0.00782	0.0173	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00694	0.0259	CbGpPWpGaD
Gallium nitrate—Lung infiltration—Isotretinoin—peripheral nervous system neoplasm	0.00693	0.0153	CcSEcCtD
Gallium nitrate—Lung infiltration—Tretinoin—peripheral nervous system neoplasm	0.00693	0.0153	CcSEcCtD
Gallium nitrate—BGLAP—FGF signaling pathway—NCAM1—peripheral nervous system neoplasm	0.00681	0.0254	CbGpPWpGaD
Gallium nitrate—IL1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00647	0.0239	CbGeAlD
Gallium nitrate—Rales—Alitretinoin—peripheral nervous system neoplasm	0.006	0.0132	CcSEcCtD
Gallium nitrate—Blindness—Tretinoin—peripheral nervous system neoplasm	0.00587	0.013	CcSEcCtD
Gallium nitrate—Blindness—Isotretinoin—peripheral nervous system neoplasm	0.00587	0.013	CcSEcCtD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—IFNB1—peripheral nervous system neoplasm	0.00582	0.0217	CbGpPWpGaD
Gallium nitrate—Body temperature decreased—Tretinoin—peripheral nervous system neoplasm	0.0058	0.0128	CcSEcCtD
Gallium nitrate—Body temperature decreased—Isotretinoin—peripheral nervous system neoplasm	0.0058	0.0128	CcSEcCtD
Gallium nitrate—Hypothermia—Isotretinoin—peripheral nervous system neoplasm	0.0058	0.0128	CcSEcCtD
Gallium nitrate—Hypothermia—Tretinoin—peripheral nervous system neoplasm	0.0058	0.0128	CcSEcCtD
Gallium nitrate—TF—trigeminal ganglion—peripheral nervous system neoplasm	0.00577	0.0213	CbGeAlD
Gallium nitrate—IL1B—brainstem—peripheral nervous system neoplasm	0.00572	0.0211	CbGeAlD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00563	0.021	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00538	0.0201	CbGpPWpGaD
Gallium nitrate—Optic neuritis—Tretinoin—peripheral nervous system neoplasm	0.00528	0.0117	CcSEcCtD
Gallium nitrate—Optic neuritis—Isotretinoin—peripheral nervous system neoplasm	0.00528	0.0117	CcSEcCtD
Gallium nitrate—Lung infiltration—Alitretinoin—peripheral nervous system neoplasm	0.00525	0.0116	CcSEcCtD
Gallium nitrate—TF—brainstem—peripheral nervous system neoplasm	0.0051	0.0189	CbGeAlD
Gallium nitrate—Encephalopathy—Isotretinoin—peripheral nervous system neoplasm	0.00506	0.0112	CcSEcCtD
Gallium nitrate—Encephalopathy—Tretinoin—peripheral nervous system neoplasm	0.00506	0.0112	CcSEcCtD
Gallium nitrate—IL1B—Monoamine Transport—TH—peripheral nervous system neoplasm	0.00504	0.0188	CbGpPWpGaD
Gallium nitrate—RRM2—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00501	0.0187	CbGpPWpGaD
Gallium nitrate—IL1B—Type II interferon signaling (IFNG)—IFNB1—peripheral nervous system neoplasm	0.00452	0.0169	CbGpPWpGaD
Gallium nitrate—Blindness—Alitretinoin—peripheral nervous system neoplasm	0.00445	0.00982	CcSEcCtD
Gallium nitrate—BGLAP—Interleukin-11 Signaling Pathway—BIRC5—peripheral nervous system neoplasm	0.00442	0.0165	CbGpPWpGaD
Gallium nitrate—Body temperature decreased—Alitretinoin—peripheral nervous system neoplasm	0.00439	0.0097	CcSEcCtD
Gallium nitrate—Hypothermia—Alitretinoin—peripheral nervous system neoplasm	0.00439	0.0097	CcSEcCtD
Gallium nitrate—Blindness—Vincristine—peripheral nervous system neoplasm	0.00429	0.00946	CcSEcCtD
Gallium nitrate—Pleural effusion—Topotecan—peripheral nervous system neoplasm	0.00428	0.00944	CcSEcCtD
Gallium nitrate—Pleural effusion—Isotretinoin—peripheral nervous system neoplasm	0.00424	0.00937	CcSEcCtD
Gallium nitrate—Pleural effusion—Tretinoin—peripheral nervous system neoplasm	0.00424	0.00937	CcSEcCtD
Gallium nitrate—BGLAP—FGF signaling pathway—HGF—peripheral nervous system neoplasm	0.00413	0.0154	CbGpPWpGaD
Gallium nitrate—Optic neuritis—Alitretinoin—peripheral nervous system neoplasm	0.004	0.00884	CcSEcCtD
Gallium nitrate—ATP6V1B2—cerebellum—peripheral nervous system neoplasm	0.00386	0.0142	CbGeAlD
Gallium nitrate—Encephalopathy—Alitretinoin—peripheral nervous system neoplasm	0.00384	0.00847	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Isotretinoin—peripheral nervous system neoplasm	0.00381	0.0084	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Tretinoin—peripheral nervous system neoplasm	0.00381	0.0084	CcSEcCtD
Gallium nitrate—Blindness—Cisplatin—peripheral nervous system neoplasm	0.00379	0.00836	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Melphalan—peripheral nervous system neoplasm	0.00376	0.00829	CcSEcCtD
Gallium nitrate—TF—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.0037	0.0138	CbGpPWpGaD
Gallium nitrate—TF—Differentiation Pathway—HGF—peripheral nervous system neoplasm	0.00365	0.0136	CbGpPWpGaD
Gallium nitrate—Hypophosphataemia—Cisplatin—peripheral nervous system neoplasm	0.00361	0.00797	CcSEcCtD
Gallium nitrate—IL1B—Alzheimers Disease—PPP3R1—peripheral nervous system neoplasm	0.00355	0.0133	CbGpPWpGaD
Gallium nitrate—BGLAP—Interleukin-11 Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.00355	0.0132	CbGpPWpGaD
Gallium nitrate—Hearing impaired—Tretinoin—peripheral nervous system neoplasm	0.00341	0.00753	CcSEcCtD
Gallium nitrate—Hearing impaired—Isotretinoin—peripheral nervous system neoplasm	0.00341	0.00753	CcSEcCtD
Gallium nitrate—Optic neuritis—Cisplatin—peripheral nervous system neoplasm	0.00341	0.00753	CcSEcCtD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—peripheral nervous system neoplasm	0.00337	0.0126	CbGpPWpGaD
Gallium nitrate—BGLAP—FGF signaling pathway—MET—peripheral nervous system neoplasm	0.00325	0.0121	CbGpPWpGaD
Gallium nitrate—Pleural effusion—Alitretinoin—peripheral nervous system neoplasm	0.00322	0.0071	CcSEcCtD
Gallium nitrate—Optic neuritis—Etoposide—peripheral nervous system neoplasm	0.00313	0.0069	CcSEcCtD
Gallium nitrate—BGLAP—FGF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.00301	0.0112	CbGpPWpGaD
Gallium nitrate—Coma—Isotretinoin—peripheral nervous system neoplasm	0.00297	0.00655	CcSEcCtD
Gallium nitrate—Coma—Tretinoin—peripheral nervous system neoplasm	0.00297	0.00655	CcSEcCtD
Gallium nitrate—TF—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	0.00292	0.0109	CbGpPWpGaD
Gallium nitrate—TF—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.00292	0.0109	CbGpPWpGaD
Gallium nitrate—Hypocalcaemia—Dactinomycin—peripheral nervous system neoplasm	0.0029	0.0064	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Alitretinoin—peripheral nervous system neoplasm	0.00288	0.00637	CcSEcCtD
Gallium nitrate—TF—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.00278	0.0104	CbGpPWpGaD
Gallium nitrate—BGLAP—Regulation of retinoblastoma protein—MET—peripheral nervous system neoplasm	0.00277	0.0103	CbGpPWpGaD
Gallium nitrate—Hearing impaired—Alitretinoin—peripheral nervous system neoplasm	0.00259	0.00571	CcSEcCtD
Gallium nitrate—Renal failure acute—Tretinoin—peripheral nervous system neoplasm	0.00256	0.00564	CcSEcCtD
Gallium nitrate—Renal failure acute—Isotretinoin—peripheral nervous system neoplasm	0.00256	0.00564	CcSEcCtD
Gallium nitrate—IL1B—Type II interferon signaling (IFNG)—PTPN11—peripheral nervous system neoplasm	0.00255	0.0095	CbGpPWpGaD
Gallium nitrate—Renal failure acute—Melphalan—peripheral nervous system neoplasm	0.00252	0.00557	CcSEcCtD
Gallium nitrate—TF—cerebellum—peripheral nervous system neoplasm	0.00252	0.0093	CbGeAlD
Gallium nitrate—TF—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.00243	0.00906	CbGpPWpGaD
Gallium nitrate—Lethargy—Topotecan—peripheral nervous system neoplasm	0.00243	0.00536	CcSEcCtD
Gallium nitrate—Lethargy—Tretinoin—peripheral nervous system neoplasm	0.00241	0.00531	CcSEcCtD
Gallium nitrate—Lethargy—Isotretinoin—peripheral nervous system neoplasm	0.00241	0.00531	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—PTPN11—peripheral nervous system neoplasm	0.0024	0.00896	CbGpPWpGaD
Gallium nitrate—TF—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.00231	0.00863	CbGpPWpGaD
Gallium nitrate—IL1B—IFN-gamma pathway—PTPN11—peripheral nervous system neoplasm	0.00226	0.00842	CbGpPWpGaD
Gallium nitrate—Coma—Alitretinoin—peripheral nervous system neoplasm	0.00225	0.00497	CcSEcCtD
Gallium nitrate—Hearing impaired—Cisplatin—peripheral nervous system neoplasm	0.0022	0.00487	CcSEcCtD
Gallium nitrate—Coma—Vincristine—peripheral nervous system neoplasm	0.00217	0.00479	CcSEcCtD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00216	0.00807	CbGpPWpGaD
Gallium nitrate—BGLAP—Regulation of retinoblastoma protein—CDKN2A—peripheral nervous system neoplasm	0.00212	0.00791	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—NF1—peripheral nervous system neoplasm	0.00202	0.00754	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—IFNB1—peripheral nervous system neoplasm	0.00201	0.00749	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.002	0.00746	CbGpPWpGaD
Gallium nitrate—Lethargy—Dactinomycin—peripheral nervous system neoplasm	0.00197	0.00434	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—IFNB1—peripheral nervous system neoplasm	0.00196	0.00732	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—ABCB1—peripheral nervous system neoplasm	0.00196	0.00731	CbGpPWpGaD
Gallium nitrate—Blindness—Epirubicin—peripheral nervous system neoplasm	0.00195	0.0043	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—PPP3R1—peripheral nervous system neoplasm	0.00194	0.00725	CbGpPWpGaD
Gallium nitrate—Renal failure acute—Alitretinoin—peripheral nervous system neoplasm	0.00194	0.00427	CcSEcCtD
Gallium nitrate—Body temperature decreased—Epirubicin—peripheral nervous system neoplasm	0.00192	0.00424	CcSEcCtD
Gallium nitrate—Hypothermia—Epirubicin—peripheral nervous system neoplasm	0.00192	0.00424	CcSEcCtD
Gallium nitrate—TF—EPHB forward signaling—NRAS—peripheral nervous system neoplasm	0.00189	0.00706	CbGpPWpGaD
Gallium nitrate—Hypophosphataemia—Epirubicin—peripheral nervous system neoplasm	0.00185	0.00409	CcSEcCtD
Gallium nitrate—IL1B—IL-1 signaling pathway—PTPN11—peripheral nervous system neoplasm	0.00185	0.00692	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00183	0.00683	CbGpPWpGaD
Gallium nitrate—Lethargy—Alitretinoin—peripheral nervous system neoplasm	0.00182	0.00403	CcSEcCtD
Gallium nitrate—Blindness—Doxorubicin—peripheral nervous system neoplasm	0.0018	0.00397	CcSEcCtD
Gallium nitrate—Hypothermia—Doxorubicin—peripheral nervous system neoplasm	0.00178	0.00393	CcSEcCtD
Gallium nitrate—Body temperature decreased—Doxorubicin—peripheral nervous system neoplasm	0.00178	0.00393	CcSEcCtD
Gallium nitrate—Optic neuritis—Epirubicin—peripheral nervous system neoplasm	0.00175	0.00387	CcSEcCtD
Gallium nitrate—Hypophosphataemia—Doxorubicin—peripheral nervous system neoplasm	0.00172	0.00379	CcSEcCtD
Gallium nitrate—Renal failure acute—Cisplatin—peripheral nervous system neoplasm	0.00165	0.00364	CcSEcCtD
Gallium nitrate—Hallucination—Tretinoin—peripheral nervous system neoplasm	0.00162	0.00358	CcSEcCtD
Gallium nitrate—Hallucination—Isotretinoin—peripheral nervous system neoplasm	0.00162	0.00358	CcSEcCtD
Gallium nitrate—Optic neuritis—Doxorubicin—peripheral nervous system neoplasm	0.00162	0.00358	CcSEcCtD
Gallium nitrate—Oedema peripheral—Isotretinoin—peripheral nervous system neoplasm	0.00161	0.00355	CcSEcCtD
Gallium nitrate—Oedema peripheral—Tretinoin—peripheral nervous system neoplasm	0.00161	0.00355	CcSEcCtD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—IFNB1—peripheral nervous system neoplasm	0.00157	0.00585	CbGpPWpGaD
Gallium nitrate—BGLAP—Interleukin-11 Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.00156	0.00582	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00155	0.00578	CbGpPWpGaD
Gallium nitrate—Tinnitus—Tretinoin—peripheral nervous system neoplasm	0.00152	0.00336	CcSEcCtD
Gallium nitrate—Tinnitus—Isotretinoin—peripheral nervous system neoplasm	0.00152	0.00336	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00149	0.00556	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—HGF—peripheral nervous system neoplasm	0.00148	0.00553	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—PTPN11—peripheral nervous system neoplasm	0.00145	0.0054	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	0.00145	0.00539	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—NRAS—peripheral nervous system neoplasm	0.00144	0.00539	CbGpPWpGaD
Gallium nitrate—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00142	0.00314	CcSEcCtD
Gallium nitrate—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00142	0.00314	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00142	0.0053	CbGpPWpGaD
Gallium nitrate—Pleural effusion—Epirubicin—peripheral nervous system neoplasm	0.00141	0.00311	CcSEcCtD
Gallium nitrate—TF—EPHB forward signaling—HRAS—peripheral nervous system neoplasm	0.00138	0.00517	CbGpPWpGaD
Gallium nitrate—BGLAP—Interleukin-11 Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.00138	0.00514	CbGpPWpGaD
Gallium nitrate—Anaemia—Topotecan—peripheral nervous system neoplasm	0.00132	0.00292	CcSEcCtD
Gallium nitrate—Anaemia—Isotretinoin—peripheral nervous system neoplasm	0.00131	0.0029	CcSEcCtD
Gallium nitrate—Anaemia—Tretinoin—peripheral nervous system neoplasm	0.00131	0.0029	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—GNS—peripheral nervous system neoplasm	0.00131	0.00489	CbGpPWpGaD
Gallium nitrate—RRM2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.00131	0.00488	CbGpPWpGaD
Gallium nitrate—Pleural effusion—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.00287	CcSEcCtD
Gallium nitrate—Anaemia—Melphalan—peripheral nervous system neoplasm	0.0013	0.00286	CcSEcCtD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.00129	0.00483	CbGpPWpGaD
Gallium nitrate—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00128	0.00283	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00279	CcSEcCtD
Gallium nitrate—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00126	0.00277	CcSEcCtD
Gallium nitrate—IL1B—TCR Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.00125	0.00467	CbGpPWpGaD
Gallium nitrate—RRM2—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.00124	0.00464	CbGpPWpGaD
Gallium nitrate—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.00123	0.00272	CcSEcCtD
Gallium nitrate—Oedema peripheral—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00269	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—NTRK1—peripheral nervous system neoplasm	0.00119	0.00444	CbGpPWpGaD
Gallium nitrate—Hallucination—Vincristine—peripheral nervous system neoplasm	0.00119	0.00262	CcSEcCtD
Gallium nitrate—TF—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00119	0.00442	CbGpPWpGaD
Gallium nitrate—Hypocalcaemia—Epirubicin—peripheral nervous system neoplasm	0.00118	0.0026	CcSEcCtD
Gallium nitrate—BGLAP—FGF signaling pathway—AKT1—peripheral nervous system neoplasm	0.00117	0.00436	CbGpPWpGaD
Gallium nitrate—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00117	0.00258	CcSEcCtD
Gallium nitrate—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00258	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00258	CcSEcCtD
Gallium nitrate—IL1B—Myometrial Relaxation and Contraction Pathways—GNAS—peripheral nervous system neoplasm	0.00116	0.00435	CbGpPWpGaD
Gallium nitrate—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00116	0.00256	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00116	0.00431	CbGpPWpGaD
Gallium nitrate—Tinnitus—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00254	CcSEcCtD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00114	0.00427	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—ERBB2—peripheral nervous system neoplasm	0.00114	0.00427	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—NCAM1—peripheral nervous system neoplasm	0.00114	0.00426	CbGpPWpGaD
Gallium nitrate—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00113	0.0025	CcSEcCtD
Gallium nitrate—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00113	0.0025	CcSEcCtD
Gallium nitrate—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00112	0.00247	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—BDNF—peripheral nervous system neoplasm	0.00109	0.00407	CbGpPWpGaD
Gallium nitrate—Hypocalcaemia—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.0024	CcSEcCtD
Gallium nitrate—IL1B—Signaling by Interleukins—PTPN11—peripheral nervous system neoplasm	0.00108	0.00403	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.00108	0.00402	CbGpPWpGaD
Gallium nitrate—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00238	CcSEcCtD
Gallium nitrate—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.00237	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—HRAS—peripheral nervous system neoplasm	0.00106	0.00394	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00105	0.00232	CcSEcCtD
Gallium nitrate—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00104	0.0023	CcSEcCtD
Gallium nitrate—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00104	0.0023	CcSEcCtD
Gallium nitrate—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00104	0.0023	CcSEcCtD
Gallium nitrate—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00104	0.00229	CcSEcCtD
Gallium nitrate—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00103	0.00228	CcSEcCtD
Gallium nitrate—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00103	0.00228	CcSEcCtD
Gallium nitrate—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00103	0.00227	CcSEcCtD
Gallium nitrate—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00102	0.00225	CcSEcCtD
Gallium nitrate—Constipation—Topotecan—peripheral nervous system neoplasm	0.000999	0.00221	CcSEcCtD
Gallium nitrate—IL1B—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000995	0.00371	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—CASP3—peripheral nervous system neoplasm	0.000995	0.00371	CbGpPWpGaD
Gallium nitrate—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.000995	0.0022	CcSEcCtD
Gallium nitrate—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000991	0.00219	CcSEcCtD
Gallium nitrate—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000991	0.00219	CcSEcCtD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—TP53—peripheral nervous system neoplasm	0.000991	0.0037	CbGpPWpGaD
Gallium nitrate—Coma—Epirubicin—peripheral nervous system neoplasm	0.000985	0.00217	CcSEcCtD
Gallium nitrate—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.000983	0.00217	CcSEcCtD
Gallium nitrate—RRM2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000972	0.00363	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000963	0.00213	CcSEcCtD
Gallium nitrate—Anaemia—Vincristine—peripheral nervous system neoplasm	0.000959	0.00212	CcSEcCtD
Gallium nitrate—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000955	0.00211	CcSEcCtD
Gallium nitrate—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000955	0.00211	CcSEcCtD
Gallium nitrate—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000929	0.00205	CcSEcCtD
Gallium nitrate—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000924	0.00204	CcSEcCtD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000921	0.00344	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000918	0.00343	CbGpPWpGaD
Gallium nitrate—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000917	0.00202	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—PPP3R1—peripheral nervous system neoplasm	0.000917	0.00342	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000917	0.00202	CcSEcCtD
Gallium nitrate—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000917	0.00202	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—CDKN2A—peripheral nervous system neoplasm	0.000913	0.00341	CbGpPWpGaD
Gallium nitrate—Coma—Doxorubicin—peripheral nervous system neoplasm	0.000911	0.00201	CcSEcCtD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000904	0.00337	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IFNB1—peripheral nervous system neoplasm	0.000895	0.00334	CbGpPWpGaD
Gallium nitrate—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000886	0.00196	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00088	0.00328	CbGpPWpGaD
Gallium nitrate—IL1B—IFN-gamma pathway—AKT1—peripheral nervous system neoplasm	0.000877	0.00327	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000861	0.0019	CcSEcCtD
Gallium nitrate—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000858	0.00189	CcSEcCtD
Gallium nitrate—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000854	0.00189	CcSEcCtD
Gallium nitrate—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000854	0.00189	CcSEcCtD
Gallium nitrate—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000848	0.00187	CcSEcCtD
Gallium nitrate—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.000847	0.00187	CcSEcCtD
Gallium nitrate—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000843	0.00186	CcSEcCtD
Gallium nitrate—RRM2—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000843	0.00315	CbGpPWpGaD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—AKT1—peripheral nervous system neoplasm	0.000837	0.00312	CbGpPWpGaD
Gallium nitrate—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000827	0.00182	CcSEcCtD
Gallium nitrate—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000821	0.00181	CcSEcCtD
Gallium nitrate—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00082	0.00181	CcSEcCtD
Gallium nitrate—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00082	0.00181	CcSEcCtD
Gallium nitrate—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00081	0.00179	CcSEcCtD
Gallium nitrate—TF—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	0.000803	0.003	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.0008	0.00176	CcSEcCtD
Gallium nitrate—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000798	0.00176	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—ENO2—peripheral nervous system neoplasm	0.000794	0.00296	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000793	0.00175	CcSEcCtD
Gallium nitrate—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000793	0.00175	CcSEcCtD
Gallium nitrate—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000789	0.00174	CcSEcCtD
Gallium nitrate—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.000784	0.00173	CcSEcCtD
Gallium nitrate—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000783	0.00173	CcSEcCtD
Gallium nitrate—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000783	0.00173	CcSEcCtD
Gallium nitrate—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000781	0.00172	CcSEcCtD
Gallium nitrate—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000777	0.00171	CcSEcCtD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	0.000761	0.00284	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00076	0.00168	CcSEcCtD
Gallium nitrate—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000752	0.00166	CcSEcCtD
Gallium nitrate—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000751	0.00166	CcSEcCtD
Gallium nitrate—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000749	0.00165	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000745	0.00278	CbGpPWpGaD
Gallium nitrate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000743	0.00164	CcSEcCtD
Gallium nitrate—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000739	0.00163	CcSEcCtD
Gallium nitrate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000737	0.00163	CcSEcCtD
Gallium nitrate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000737	0.00163	CcSEcCtD
Gallium nitrate—IL1B—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000737	0.00275	CbGpPWpGaD
Gallium nitrate—Rash—Topotecan—peripheral nervous system neoplasm	0.000737	0.00163	CcSEcCtD
Gallium nitrate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000736	0.00162	CcSEcCtD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000733	0.00273	CbGpPWpGaD
Gallium nitrate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000731	0.00161	CcSEcCtD
Gallium nitrate—Rash—Tretinoin—peripheral nervous system neoplasm	0.000731	0.00161	CcSEcCtD
Gallium nitrate—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000731	0.00161	CcSEcCtD
Gallium nitrate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00073	0.00161	CcSEcCtD
Gallium nitrate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00073	0.00161	CcSEcCtD
Gallium nitrate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000728	0.00161	CcSEcCtD
Gallium nitrate—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000724	0.0016	CcSEcCtD
Gallium nitrate—Constipation—Vincristine—peripheral nervous system neoplasm	0.000724	0.0016	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.000722	0.00269	CbGpPWpGaD
Gallium nitrate—Rash—Melphalan—peripheral nervous system neoplasm	0.000722	0.00159	CcSEcCtD
Gallium nitrate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000721	0.00159	CcSEcCtD
Gallium nitrate—IL1B—IL-1 signaling pathway—AKT1—peripheral nervous system neoplasm	0.00072	0.00269	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000719	0.00268	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000698	0.00154	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000696	0.0026	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000695	0.00153	CcSEcCtD
Gallium nitrate—Nausea—Topotecan—peripheral nervous system neoplasm	0.000694	0.00153	CcSEcCtD
Gallium nitrate—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000692	0.00153	CcSEcCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HGF—peripheral nervous system neoplasm	0.000691	0.00258	CbGpPWpGaD
Gallium nitrate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000689	0.00152	CcSEcCtD
Gallium nitrate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000689	0.00152	CcSEcCtD
Gallium nitrate—Nausea—Melphalan—peripheral nervous system neoplasm	0.00068	0.0015	CcSEcCtD
Gallium nitrate—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000672	0.00148	CcSEcCtD
Gallium nitrate—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000669	0.00148	CcSEcCtD
Gallium nitrate—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000669	0.00148	CcSEcCtD
Gallium nitrate—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000667	0.00147	CcSEcCtD
Gallium nitrate—TF—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000667	0.00249	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000657	0.00245	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—NRAS—peripheral nervous system neoplasm	0.00065	0.00242	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	0.000649	0.00242	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000648	0.00143	CcSEcCtD
Gallium nitrate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000647	0.00143	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000642	0.0024	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—SLC2A1—peripheral nervous system neoplasm	0.00064	0.00239	CbGpPWpGaD
Gallium nitrate—IL1B—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000638	0.00238	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	0.000636	0.00237	CbGpPWpGaD
Gallium nitrate—TF—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000627	0.00234	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000624	0.00138	CcSEcCtD
Gallium nitrate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000622	0.00137	CcSEcCtD
Gallium nitrate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000617	0.00136	CcSEcCtD
Gallium nitrate—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000616	0.00136	CcSEcCtD
Gallium nitrate—RRM2—G1/S Transition—MYC—peripheral nervous system neoplasm	0.000612	0.00228	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000611	0.00135	CcSEcCtD
Gallium nitrate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000603	0.00133	CcSEcCtD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000602	0.00225	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000601	0.00133	CcSEcCtD
Gallium nitrate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000598	0.00132	CcSEcCtD
Gallium nitrate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000592	0.00131	CcSEcCtD
Gallium nitrate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000587	0.00129	CcSEcCtD
Gallium nitrate—TF—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000583	0.00218	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—AURKA—peripheral nervous system neoplasm	0.000581	0.00217	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000579	0.00128	CcSEcCtD
Gallium nitrate—IL1B—Immune System—CD55—peripheral nervous system neoplasm	0.000578	0.00216	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000578	0.00216	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000565	0.00125	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000564	0.0021	CbGpPWpGaD
Gallium nitrate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000563	0.00124	CcSEcCtD
Gallium nitrate—IL1B—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	0.000562	0.0021	CbGpPWpGaD
Gallium nitrate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000559	0.00123	CcSEcCtD
Gallium nitrate—TF—Hemostasis—HGF—peripheral nervous system neoplasm	0.000555	0.00207	CbGpPWpGaD
Gallium nitrate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000554	0.00122	CcSEcCtD
Gallium nitrate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000554	0.00122	CcSEcCtD
Gallium nitrate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000552	0.00122	CcSEcCtD
Gallium nitrate—IL1B—TCR Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.00055	0.00205	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—CASP3—peripheral nervous system neoplasm	0.000544	0.00203	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000542	0.0012	CcSEcCtD
Gallium nitrate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000538	0.00119	CcSEcCtD
Gallium nitrate—Rash—Vincristine—peripheral nervous system neoplasm	0.000534	0.00118	CcSEcCtD
Gallium nitrate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000533	0.00118	CcSEcCtD
Gallium nitrate—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000533	0.00118	CcSEcCtD
Gallium nitrate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000522	0.00115	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle—CHEK2—peripheral nervous system neoplasm	0.000519	0.00194	CbGpPWpGaD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	0.000515	0.00192	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000512	0.00113	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—TP53—peripheral nervous system neoplasm	0.000508	0.0019	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000505	0.00112	CcSEcCtD
Gallium nitrate—TF—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000505	0.00188	CbGpPWpGaD
Gallium nitrate—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000505	0.00111	CcSEcCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—PTPN11—peripheral nervous system neoplasm	0.000504	0.00188	CbGpPWpGaD
Gallium nitrate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000503	0.00111	CcSEcCtD
Gallium nitrate—TF—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000495	0.00185	CbGpPWpGaD
Gallium nitrate—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000493	0.00109	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—HRAS—peripheral nervous system neoplasm	0.000486	0.00181	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000486	0.00181	CbGpPWpGaD
Gallium nitrate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000485	0.00107	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000482	0.0018	CbGpPWpGaD
Gallium nitrate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000476	0.00105	CcSEcCtD
Gallium nitrate—IL1B—Signaling by Interleukins—HRAS—peripheral nervous system neoplasm	0.000475	0.00177	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GNS—peripheral nervous system neoplasm	0.000475	0.00177	CbGpPWpGaD
Gallium nitrate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000472	0.00104	CcSEcCtD
Gallium nitrate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000472	0.00104	CcSEcCtD
Gallium nitrate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000471	0.00104	CcSEcCtD
Gallium nitrate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000469	0.00104	CcSEcCtD
Gallium nitrate—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.00103	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000463	0.00173	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—NRAS—peripheral nervous system neoplasm	0.000456	0.0017	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—NME1—peripheral nervous system neoplasm	0.000455	0.0017	CbGpPWpGaD
Gallium nitrate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000445	0.000981	CcSEcCtD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000439	0.00164	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CD34—peripheral nervous system neoplasm	0.000438	0.00164	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—COX2—peripheral nervous system neoplasm	0.000438	0.00164	CbGpPWpGaD
Gallium nitrate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000436	0.000962	CcSEcCtD
Gallium nitrate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.000962	CcSEcCtD
Gallium nitrate—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000435	0.000961	CcSEcCtD
Gallium nitrate—Rash—Etoposide—peripheral nervous system neoplasm	0.000432	0.000954	CcSEcCtD
Gallium nitrate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000432	0.000954	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—MYC—peripheral nervous system neoplasm	0.000425	0.00159	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000422	0.00157	CbGpPWpGaD
Gallium nitrate—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000422	0.000931	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	0.000421	0.00157	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000412	0.00154	CbGpPWpGaD
Gallium nitrate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000407	0.000899	CcSEcCtD
Gallium nitrate—TF—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000405	0.00151	CbGpPWpGaD
Gallium nitrate—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000889	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000393	0.00147	CbGpPWpGaD
Gallium nitrate—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000861	CcSEcCtD
Gallium nitrate—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000856	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle—BIRC5—peripheral nervous system neoplasm	0.000376	0.0014	CbGpPWpGaD
Gallium nitrate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000375	0.000828	CcSEcCtD
Gallium nitrate—IL1B—Immune System—NCAM1—peripheral nervous system neoplasm	0.000373	0.00139	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000361	0.00135	CbGpPWpGaD
Gallium nitrate—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000792	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—PTPN11—peripheral nervous system neoplasm	0.000358	0.00134	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—TP53—peripheral nervous system neoplasm	0.000349	0.0013	CbGpPWpGaD
Gallium nitrate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000766	CcSEcCtD
Gallium nitrate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000762	CcSEcCtD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.000343	0.00128	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000756	CcSEcCtD
Gallium nitrate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000726	CcSEcCtD
Gallium nitrate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000705	CcSEcCtD
Gallium nitrate—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.0007	CcSEcCtD
Gallium nitrate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000699	CcSEcCtD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	0.000305	0.00114	CbGpPWpGaD
Gallium nitrate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000671	CcSEcCtD
Gallium nitrate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000671	CcSEcCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—NRAS—peripheral nervous system neoplasm	0.000303	0.00113	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000295	0.0011	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000647	CcSEcCtD
Gallium nitrate—IL1B—Immune System—IFNB1—peripheral nervous system neoplasm	0.000292	0.00109	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000288	0.00107	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000625	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—ERBB2—peripheral nervous system neoplasm	0.000283	0.00106	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000621	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	0.000279	0.00104	CbGpPWpGaD
Gallium nitrate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000272	0.0006	CcSEcCtD
Gallium nitrate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000581	CcSEcCtD
Gallium nitrate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000578	CcSEcCtD
Gallium nitrate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000555	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000251	0.000935	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	0.000249	0.000931	CbGpPWpGaD
Gallium nitrate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000244	0.00054	CcSEcCtD
Gallium nitrate—TF—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000244	0.000909	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000537	CcSEcCtD
Gallium nitrate—RRM2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000243	0.000907	CbGpPWpGaD
Gallium nitrate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000535	CcSEcCtD
Gallium nitrate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000535	CcSEcCtD
Gallium nitrate—RRM2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000232	0.000865	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—TH—peripheral nervous system neoplasm	0.000229	0.000853	CbGpPWpGaD
Gallium nitrate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000504	CcSEcCtD
Gallium nitrate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000499	CcSEcCtD
Gallium nitrate—IL1B—Immune System—HGF—peripheral nervous system neoplasm	0.000226	0.000843	CbGpPWpGaD
Gallium nitrate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000495	CcSEcCtD
Gallium nitrate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000495	CcSEcCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HRAS—peripheral nervous system neoplasm	0.000222	0.000828	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—NRAS—peripheral nervous system neoplasm	0.000215	0.000803	CbGpPWpGaD
Gallium nitrate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000466	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—MYC—peripheral nervous system neoplasm	0.0002	0.000748	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000198	0.000739	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	0.000189	0.000706	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000187	0.000696	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—TP53—peripheral nervous system neoplasm	0.000186	0.000695	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000183	0.000683	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.00018	0.000671	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000178	0.000665	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—MYC—peripheral nervous system neoplasm	0.000169	0.000631	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—PTPN11—peripheral nervous system neoplasm	0.000165	0.000615	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—HRAS—peripheral nervous system neoplasm	0.000157	0.000588	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000157	0.000587	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000151	0.000562	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.00014	0.000524	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—AKT1—peripheral nervous system neoplasm	0.000139	0.000519	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—TP53—peripheral nervous system neoplasm	0.000139	0.000518	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—ERBB2—peripheral nervous system neoplasm	0.00013	0.000486	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000115	0.00043	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.00011	0.000411	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—NRAS—peripheral nervous system neoplasm	9.9e-05	0.00037	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.74e-05	0.000363	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—HRAS—peripheral nervous system neoplasm	7.25e-05	0.00027	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—AKT1—peripheral nervous system neoplasm	6.4e-05	0.000239	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—AKT1—peripheral nervous system neoplasm	5.04e-05	0.000188	CbGpPWpGaD
